Showing results (101-110 of 261) with videos related to
Sort By:
Pageof 27
British Journal of Pharmacology|November 15, 2025
Novel approaches for drug development against chronic primary pain: A systematic reviewValéria Tékus, Éva Borbély, Andreas Goebel, et al.Frontiers in Psychiatry|April 4, 2022
Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic ReviewMagdalena Mroczek, Ignazio Maniscalco, Manon Sendel, et al.Cephalalgia : an International Journal of Headache|February 18, 2020
Do doctors treat themselves differently than their patients? Study on the self-treatment of migraine among German neurologists and pain specialistsLeonie C Hansen, Charly Gaul, Esther Pogatzki-Zahn, et al.Journal of Neurology|August 19, 2004
Idiopathic restless legs syndrome: abnormalities in central somatosensory processingJörn Schattschneider, Andre Bode, Gunnar Wasner, et al.Current Medical Research and Opinion|July 10, 2012
Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgiaRainer Sabatowski, Guy Hans, Ingrid Tacken, et al.Pain Reports|February 2, 2019
Dynamic of the somatosensory system in postherpetic neuralgiaJanne Gierthmühlen, Olga Braig, Stefanie Rehm, et al.Journal of Neurophysiology|February 22, 2018
Mechano- and thermosensitivity of injured muscle afferents 20 to 80 days after nerve injuryJan Tode, Irina Kirillova-Woytke, Vanessa H Rausch, et al.Clinical Drug Investigation|May 13, 2009
Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trialAndreas Binder, Jean Bruxelle, Peter Rogers, et al.Current Medical Research and Opinion|June 3, 2009
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT studyRalf Baron, Victor Mayoral, Göran Leijon, et al.Journal of Neuro-Oncology|August 8, 2002
Docetaxel-induced nail changes--a neurogenic mechanism: a case reportGunnar Wasner, Felix Hilpert, Jörn Schattschneider, et al.Pageof 27